humanitarian Archived signal

Human medicines European public assessment report (EPAR): Ordspono, odronextamab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Pemetrexed Baxter, pemetrexed, Date of authorisation: 09/12/2022, Status: Withdrawn

Reported by EMA What Is New Oct 2, 2026 · 13:01 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Ordspono, odronextamab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised13:01 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Ordspono, odronextamab, Date of authorisation: 22/08/2024, Revision: 2, Status: Authorised13:01 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Sialanar, glycopyrronium bromide, Date of authorisation: 15/09/2016, Revision: 13, Status: Authorised12:58 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Sialanar, glycopyrronium bromide, Date of authorisation: 15/09/2016, Revision: 13, Status: Authorised12:58 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Revision: 2, Status: Authorised12:28 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Andembry, garadacimab, Date of authorisation: 10/02/2025, Revision: 2, Status: Authorised12:28 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 48, Status: Authorised12:19 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 48, Status: Authorised12:19 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Itvisma, onasemnogene abeparvovec, Date of authorisation: 30/06/2026, Revision: 1, Status: Authorised10:18 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Itvisma, onasemnogene abeparvovec, Date of authorisation: 30/06/2026, Revision: 1, Status: Authorised10:18 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Bysumlog, insulin lispro, Date of authorisation: 06/05/2026, Revision: 2, Status: Authorised09:57 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Bysumlog, insulin lispro, Date of authorisation: 06/05/2026, Revision: 2, Status: Authorised09:57 UTC

INCIDENT EVOLUTION

3 recorded states

Oct 2 · 13:11 UTC

Signal first indexedP2 · 99% quality · 2 sources

Oct 2 · 13:12 UTC

Headline updatedP2 · 99% quality · 2 sources

Oct 2 · 13:20 UTC

Source details updatedP2 · 99% quality · 2 sources

Explore this day in the archive →